Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Critical Care Compendium1001 Topics in Intensive Care & Acute Medicine, pp. 349 - 411Publisher: Cambridge University PressPrint publication year: 2023
References
Bibliography
Honarmand, K, Rafay, H, Le, J, et al. A systematic review of risk factors for sleep disruption in critically ill adults. Crit Care Med 2020; 48: 1066.CrossRefGoogle ScholarPubMed
Bibliography
Becker, C. Diseases of calcium metabolism and metabolic bone disease. In: Scientific American Medicine. Endocrinology & Metabolism. Hamilton: Dekker Medicine. 2020.Google Scholar
Singer, FR. Clinical efficacy of salmon calcitonin in Paget’s disease of bone. Calcif Tissue Int 1991; 49 (suppl. 2): S7.CrossRefGoogle ScholarPubMed
Singer, FR. Paget’s disease of bone. In: De Groot, LJ, ed. Endocrinology. Philadelphia. 1995; p 1259.Google Scholar
Singer, FR, Minoofar, PN. Bisphosphonates in the treatment of disorders of mineral metabolism. Adv Endocrinol Metab 1995; 6: 259.Google Scholar
Bibliography
Boeck, L, Graf, R, Eggimann, P, et al. Pancreatic stone protein: a marker of organ failure and outcome in ventilator-associated pneumonia. Chest 2011; 140: 925.Google Scholar
De Waele, JJ. Pancreatic stone protein for predicting outcome in peritonitis: limitations and challenges. Crit Care Med 2013; 41: 1150.CrossRefGoogle ScholarPubMed
Graf, R, Schiesser, M, Reding, T, et al. Exocrine meets endocrine: pancreatic stone protein and regenerating protein – two sides of the same coin. J Surg Res 2006; 133: 113.CrossRefGoogle ScholarPubMed
Bibliography
Baker, S. Diagnosis and management of acute pancreatitis. Crit Care Resusc 2004; 6: 17.Google ScholarPubMed
Basnayake, C, Ratnam, D. Blood tests for acute pancreatitis. Aust Prescriber 2015; 38: 128.Google Scholar
Berger, HG, Matsuno, S, Cameron, JL, eds. Diseases of the Pancreas. Berlin: Springer. 2008.Google Scholar
Chowdhury, RS, Forsmark, CE. Review article: pancreatic function testing. Aliment Pharmacol Ther 2003; 17: 733.CrossRefGoogle ScholarPubMed
Dellinger, EP, Tellado, JM, Soto, NE, et al. Early antibiotic treatment for severe acute necrotizing pancreatitis. Ann Surg 2007; 245: 674.Google Scholar
Dervenis, C, Bassi, C. Evidence-based assessment of severity and management of acute pancreatitis. Br J Surg 2000; 87: 257.Google Scholar
Entock, FC, Chong, P, Menezes, N, et al. A randomized study of early nasogastric versus nasojejunal feeding in severe acute pancreatitis. Am J Gastroenterol 2005; 100: 432.CrossRefGoogle Scholar
Go, VLW, et al., eds. The Pancreas: Biology, Pathobiology and Diseases. New York: Raven Press. 1993.Google Scholar
Green, PHR, Tall, AR. Drugs, alcohol and malabsorption. Am J Med 1979; 67: 1066.CrossRefGoogle ScholarPubMed
Hasibeder, WR, Torgersen, C, Rieger, M, et al. Critical care of the patient with acute pancreatitis. Anaesth Intens Care 2009; 37: 190.Google Scholar
Howes, N, Greenhall, W, Stocken, DD, et al. Cationic trypsinogen mutations and pancreatitis. Gastroenterol Clin North Am 2004; 33: 767.CrossRefGoogle ScholarPubMed
Layer, P, Yamamoto, H, Kalthoff, L, et al. The different courses of early- and late-onset idiopathic and alcoholic chronic pancreatitis. Gastroenterology 1994; 107: 1481.Google Scholar
Malledant, Y, Malbrain, MLNG, Reuter, DA. What’s new in the management of severe acute pancreatitis. Intens Care Med 2015; 41: 1957.CrossRefGoogle ScholarPubMed
Marshall, JB. Acute pancreatitis: a review with an emphasis on new developments. Arch Intern Med 1993; 153: 1185.Google Scholar
Marshall, JC. Surgical approaches to the management of acute severe necrotizing pancreatitis. Curr Opin Crit Care 1999; 5: 159.CrossRefGoogle Scholar
Nathens, AB, Curtis, JR, Beale, RJ, et al. Management of the critically ill patient with severe acute pancreatitis. Crit Care Med 2004; 32: 2524.Google Scholar
Nesvaderani, M, Eslick, GD, Cox, MR. Acute pancreatitis: update on management. Med J Aust 2016; 202: 420.CrossRefGoogle Scholar
Pastor, CM, Matthay, MA, Frossard, L-L. Pancreatitis-associated acute lung injury: new insights. Chest 2003; 124: 2341.CrossRefGoogle ScholarPubMed
Rotstein, OD. Surgical approach #1 to severe necrotizing pancreatitis. Curr Opin Crit Care 1999; 5: 160.CrossRefGoogle Scholar
Sheth, S, Ketwaroo, G, Freedman, S. Diseases of the pancreas. In: Scientific American Medicine. Gastroenterology. Hamilton: Dekker Medicine. 2020.Google Scholar
Shields, CJ, Winter, DC, Redmond, HP. Lung injury in acute pancreatitis: mechanisms, prevention, and therapy. Curr Opin Crit Care 2002; 8: 158.Google Scholar
Starr, MG. Surgical approach #2 to severe necrotizing pancreatitis. Curr Opin Crit Care 1999; 5: 162.Google Scholar
Steer, ML, Meldolesi, J. The cell biology of experimental pancreatitis. N Engl J Med 1987; 316: 144.Google Scholar
Steer, ML, Waxman, I, Freedman, S. Chronic pancreatitis. N Engl J Med 1995; 332: 1482.Google Scholar
Tattersall, SJN, Apte, MV, Wilson, JS. A fire inside: current concepts in chronic pancreatitis. Intern Med J 2008; 38: 592.Google Scholar
Wyncoll, DL. The management of severe acute necrotizing pancreatitis: an evidence-based review of the literature. Intens Care Med 1999; 25: 146.Google Scholar
Yousaf, M, McCallion, K, Diamond, T. Management of severe acute pancreatitis. Br J Surg 2003; 90: 407.Google Scholar
Bibliography
Lyons, MK, Meyer, FB. Cerebrospinal fluid physiology and the management of increased intracranial pressure. Mayo Clin Proc 1990; 65: 684.Google Scholar
Bibliography
Im, JG, Chang, KH, Reeder, MM. Current diagnostic imaging of pulmonary and cerebral paragonimiasis, with pathological correlation. Semin Roentgenol 1997; 32:301.Google Scholar
Pachucki, CT, Levandowski, RA, Brown, VA, et al. American paragonimiasis treated with praziquantel. N Engl J Med 1984; 311: 582.Google Scholar
Bibliography
Bibliography
Cascino, TL. Neurologic complications of systemic cancer. Med Clin North Am 1993; 77: 265.Google Scholar
Clamon, GH, Evans, WK, Shepherd, FA, et al. Myasthenic syndrome and small cell cancer of the lung: variable response to antineoplastic therapy. Arch Intern Med 1984; 144: 999.CrossRefGoogle ScholarPubMed
Cohen, PR, Talpaz, M, Kurzrock, R. Malignancy-associated Sweet’s syndrome: review of the world literature. J Clin Oncol 1988; 6: 1887.CrossRefGoogle ScholarPubMed
Cronin, RE, Kaehny, WD, Miller, PD, et al. Renal cell carcinoma: unusual systemic manifestations. Medicine 1976; 55: 291.Google Scholar
Mallette, LE. The parathyroid polyhormones: new concepts in the spectrum of peptide hormone action. Endocr Rev 1991; 12: 110.Google Scholar
O’Neill, JH, Murray, NM, Newsom-Davis, J. The Lambert-Eaton myasthenic syndrome. Brain 1988; 111: 577.Google Scholar
Peterson, K, Rosenblum, MK, Kotanides, H, et al. Paraneoplastic cerebellar degeneration. Neurology 1992; 42: 1931.Google Scholar
Ruther, U, Nunnensiek, C, Bokemeyer, C, eds. Paraneoplastic Syndromes. Basel: Karger. 1998.CrossRefGoogle Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Ariyama, J, Shimada, H, Aono, M, et al. Propofol improves recovery from paraquat acute toxicity in vitro and in vivo. Intens Care Med 2000; 26: 981.Google Scholar
Gawarammana, IB, Buckley, NA. Medical management of paraquat ingestion. Br J Clin Pharmacol 2011; 72: 745.CrossRefGoogle ScholarPubMed
Lin, JL, Lin-Tan, DT, Chen, KH, et al. Repeated pulse of methylprednisolone and cyclophosphamide with continuous dexamethasone therapy for patients with severe paraquat poisoning. Crit Care Med 2006; 34: 368.CrossRefGoogle ScholarPubMed
Ng, LL, Naik, RB, Polak, A. Paraquat ingestion with methaemoglobinaemia treated with methylene blue. BMJ 1982; 284: 1445.Google Scholar
Proudfoot, AT, Stewart, MS, Levitt, T, et al. Paraquat poisoning: significance of plasma paraquat concentrations. Lancet 1979; 2: 330.CrossRefGoogle ScholarPubMed
Senarathna, L, Eddleston, M, Wilks, MF, et al. Prediction of outcome after paraquat poisoning by measurement of paraquat concentration. QJM 2009; 102: 251.CrossRefGoogle ScholarPubMed
Suzuki, K, Takasu, N, Arita, S, et al. Evaluation of severity indexes of patients with paraquat poisoning. Hum Exp Toxicol 1991; 10: 21.Google Scholar
Vale, JA, Meredith, TJ, Buckley, BM. Paraquat poisoning: clinical features and immediate general management. Hum Toxicol 1987; 6: 41.Google Scholar
Bibliography
Elston, D. Infestations. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Henry, DH, Spivak, JL. Clinical use of erythropoietin. Curr Opinion Hematol 1995; 2: 118.Google Scholar
Hillmen, P, Lewis, SM, Bessler, M, et al. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med 1995; 333: 1253.Google Scholar
Young, NS, Meyers, G, Schrezenmeier, H, et al. The management of paroxysmal nocturnal hemoglobinuria: recent advances in diagnosis and treatment and new hope for patients. Semin Hematol 2009; 46: S1.Google Scholar
Bibliography
Eisinger, RS, Islam, S. Caring for people with untreated pectus excavatum. Chest 2020; 157: 590.CrossRefGoogle ScholarPubMed
Fonkalsrud, EW, Dunn, JC, Atkinson, JB. Repair of pectus excavatum deformities: 30 years of experience in 375 patients. Ann Surg 2000; 231: 443.Google Scholar
Bibliography
Elston, D. Infestations. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Usha, V, Gopalakrishnan Nair, TV. A comparative study of oral ivermectin and topical permethrin cream in the treatment of scabies. J Am Acad Dermatol 2000: 42: 236.Google Scholar
Bibliography
Ahmed, AR, Spiegelman, Z, Cavacini, LA, et al. Treatment of pemphigus vulgaris with rituximab and intravenous immune globulin. New Engl J Med 2006; 355: 1772.Google Scholar
Bystryn, JC, Jiao, D, Natow, S. Treatment of pemphigus with intravenous immunoglobulin. J Am Acad Dermatol 2002; 47: 358.Google Scholar
Canizares, MJ, Smith, DI, Conners, MS, et al. Successful treatment of mucous membrane pemphigoid with etanercept in 3 patients. Arch Dermatol 2006; 142: 1457.Google Scholar
Jolles, S, Hughes, J, Whittaker, S. Dermatological uses of high-dose intravenous immunoglobulin. Arch Dermatol 1998; 134: 80.Google Scholar
Stanley, JR, Amagai, M. Pemphigus, bullous impetigo and staphylococcal scalded skin syndrome. N Engl J Med 2006; 355: 1800.Google Scholar
Turner, MS, Sutton, D, Sauder, DN. The use of plasmapheresis and immunosuppression in the treatment of pemphigus vulgaris. J Am Acad Dermatol 2000; 43: 1058.Google Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Adler, Y, Charron, P, Imazio, M, et al. Guidelines for the diagnosis and management of pericardial disease. Eur heart J 2015; 36: 2921.Google Scholar
Chiabrando, JG, Bonaventura, A, Vecchie, A, et al. Management of acute and recurrent pericarditis. JACC State-of-the-Art Review. J Am Coll Cardiol 2020; 75: 76.Google Scholar
Imazio, M, Gaita, F, LeWinter, M. Evaluation and treatment of pericarditis: a systematic review. JAMA 2015; 314: 1498.Google Scholar
Lazaros, G, Vlachopoulos, C. Acute pericarditis clinical features and outcome: an update on the latest evidence. Chest 2020; 158: 2262.Google Scholar
Bibliography
Knochel, J. Neuromuscular manifestations of electrolyte disorders. Am J Med 1982; 72: 521.Google Scholar
Bibliography
Romain, M, Sviri, S, Linton, DM, et al. The role of vitamin B12 in the critically ill – a review. Anaesth Intens Care 2016; 44: 447.Google Scholar
Wald, NJ, Bower, C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 1994; 343: 307.Google Scholar
Bibliography
Bagshaw, SM, Stelfox, HT, Iwashyna, TJ, et al. Timing of onset of persistent critical illness: a multi-centre retrospective cohort study. Intens Care Med 2019; 44: 2134.Google Scholar
Darvall, JN, Boonstra, T, Norman, J, et al. Persistent critical illness: baseline characteristics, intensive care course, and cause of death. Crit Care Resusc 2019; 21: 110.Google Scholar
Iwashyna, TJ, Hodgson, CL, Pilcher, D, et al. Towards defining persistent critical illness and other varieties of chronic critical illness. Crit Care Resusc 2015; 17: 215.Google Scholar
Nelson, JE, Cox, CE, Hope, AA, et al. Chronic critical illness. Am J Respir Crit Care Med 2010; 182: 446.CrossRefGoogle ScholarPubMed
Sakusic, A, Gajic, O. Chronic critical illness: unintended consequence of intensive care medicine. Lancet Respir Med 2016; 4: 531.Google Scholar
Viglianti, EM, Bagshaw, SM, Bellomo, R, et al. Hospital-level variation in the development of persistent critical illness. Intens Care Med 2020; 46: 1567.Google Scholar
Bibliography
Alderazi, Y, Yeh, MW, Robinson, BG, et al. Phaeochromocytoma: current concepts. Med J Aust 2005; 183: 201.Google Scholar
Bravo, EL, Gifford, RW. Pheochromocytoma: diagnosis, localization and management. N Engl J Med 1984; 311: 1298.Google Scholar
Bravo, EL, Tagle, R. Pheochromocytoma: state-of-the-art and future prospects. Endocr Rev 2003; 24: 539.Google Scholar
Daly, PA, Landsberg, L. Phaeochromocytoma: diagnosis and management. Bailliere’s Clin Endocrinol Metab 1992; 6: 143.CrossRefGoogle ScholarPubMed
Golub, MS, Tuck, ML. Diagnostic and therapeutic strategies in pheochromocytoma. Endocrinologist 1992; 2: 101.Google Scholar
Lenders, JW, Pacak, K, Walther, MM, et al. Biochemical diagnosis of pheochromocytoma: which test is best? JAMA 2002; 287: 1427.Google Scholar
Naranjo, J, Dodd, S, Martin, YN. Perioperative management of pheochromocytoma. J Cardiothorac Vasc Anesth 2017; 31: 1427.Google Scholar
Sutton, MG, Sheps, SG, Lie, JT. Prevalence of clinically unsuspected pheochromocytoma. Mayo Clin Proc 1981; 56: 354.Google Scholar
Whalen, RK, Althausen, AF, Daniels, GH. Extra-adrenal pheochromocytoma. J Urol 1992; 147: 1.Google Scholar
Bibliography
Grimes, PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453.Google Scholar
Grimes, PE. Disorders of pigmentation. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Hendrix, JD, Greer, KE. Cutaneous hyperpigmentation caused by systemic drugs. Int J Dermatol 1992; 31: 458.Google Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Masuda, A, Hirota, K, Satone, T, et al. Pink urine during propofol anesthesia. Anesth Analg 1996; 83: 666.Google Scholar
Bibliography
Baylis, PH. Posterior pituitary function in health and disease. Clin Endocrinol Metab 1983; 12: 747.Google Scholar
Bills, DC, Meyer, FB, Laws, ER, et al. A retrospective analysis of pituitary apoplexy. Neurosurgery 1993; 33: 602.Google Scholar
Boonen, E, Van den Berghe, G. Understanding the HPA response to critical illness: novel insights with clinical implications. Intens Care Med 2015; 41: 131.Google Scholar
Chrousos, GP. The hypothalamic-pituitary-adrenal axis and immune-mediated inflammation. N Engl J Med 1995; 332: 1351.Google Scholar
Editorial. Corticosteroids and hypothalamic-pituitary-adrenocortical function. BMJ 1980; 280: 813.Google Scholar
Hoffman, DM, Ho, KKY. Growth hormone deficiency in adults: to treat or not to treat. Aust NZ J Med 1999; 29: 342.Google Scholar
Holland, J, Bakker, J, Feelders, RA. What’s new on the HPA axis? Intens Care Med 2015; 41: 1477.Google Scholar
Magner, JA. Thyroid-stimulating hormone: biosynthesis, cell biology, and bioactivity. Endocrinol Rev 1990; 11: 354.Google Scholar
Melmed, S. Pituitary. In: Scientific American Medicine. Endocrinology & Metabolism. Hamilton: Dekker Medicine. 2020.Google Scholar
Molitch, ME, Russell, EJ. The pituitary ‘incidentaloma’. Ann Intern Med 1990; 112: 925.Google Scholar
Russell, JA, Walley, KR, Singer, J, et al. Vasopressin versus norepinephrine infusion in patients with septic shock. N Engl J Med 2008; 358: 877.Google Scholar
Sharshar, T, Carlier, R, Blanchard, A, et al. Depletion of neurohypophyseal content of vasopressin in septic shock. Crit Care Med 2002; 30: 497.Google Scholar
Shupnik, MA, Ridgway, EC, Chin, WW. Molecular biology of thyrotropin. Endocr Rev 1989; 10: 459.Google Scholar
Van den Berghe, G, de Zegher, F. Anterior pituitary function during critical illness and dopamine treatment. Crit Care Med 1996; 24: 1580.Google Scholar
Vokes, TJ, Robertson, GL. Disorders of antidiuretic hormone. Endocrinol Metab Clin North Am 1988; 17: 281.Google Scholar
Bibliography
Butler, T. A clinical study of bubonic plague: observations of the 1970 Vietnam epidemic with emphasis on coagulation studies, skin histology and electrocardiograms. Am J Med 1972; 53: 268.Google Scholar
Inglesby, TV, Dennis, DT, Henderson, DA, et al. Plague as a biological weapon: medical and public health management. JAMA 2000; 283: 2281.Google Scholar
Liles, WC. Infections due to brucella, francisella, yersinia pestis, and bartonella. In: Scientific American Medicine. Infectious Disease. Hamilton: Dekker Medicine. 2020.Google Scholar
Von Reyn, CF, Weber, NS, Tempest, B, et al. Epidemiologic and clinical features of an outbreak of bubonic plague in New Mexico. J Infect Dis 1977; 136: 489.Google Scholar
Whitby, M, Ruff, TA, Street, AC, et al. Biological agents as weapons 2: anthrax and plague. Med J Aust 2002; 176: 605.Google Scholar
Bibliography
Couriel, D, Weinstein, R. Complications of therapeutic plasma exchange: a recent assessment. J Clin Apheresis 1994; 9: 1.Google Scholar
Madore, F. Plasmapheresis. In: Scientific American Medicine. Nephrology. Hamilton: Dekker Medicine. 2020.Google Scholar
Reeves, HM, Winters, JL. The mechanisms of action of plasma exchange. Br J Haematol 2014; 164: 342.Google Scholar
Reimann, PM, Mason, PD. Plasmapheresis: technique and complications. Intens Care Med 1990; 16: 3.Google Scholar
Rimmer, E, Houston, BL, Kumar, A, et al. The efficacy and safety of plasma exchange in patients with sepsis and septic shock: a systematic review and meta-analysis. Crit Care 2014; 18: 699.Google Scholar
Bibliography
Cattaneo, M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003; 1: 1628.Google Scholar
Desborough, MJR, Oakland, KA, Landon, G, et al. Desmopressin for treatment of platelet dysfunction and reversal of antiplatelet agents: a systematic review and meta-analysis of randomized controlled trials. J Thromb Haemost 2017; 15: 263.Google Scholar
Ferrara, JLM. The febrile platelet transfusion reaction: a cytokine shower. Transfusion 1995; 35: 89.Google Scholar
George, JN, Shattil, SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324: 27.Google Scholar
Lacoste, L, Hung, J, Lam, JY. Acute and delayed antithrombotic effects of alcohol in humans. Am J Cardiol 2001; 87: 82.Google Scholar
Leung, LLK, Zehnder, JL. Platelet disorders. In: Scientific American Medicine. Hematology. Hamilton: Dekker Medicine. 2020.Google Scholar
Marder, VJ, Aird, WC, Bennett, JS, et al., eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. 6th edition. Philadelphia: Lippincott Williams & Wilkins. 2012.Google Scholar
Nurden, AT, Nurden, P. Inherited disorders of platelet function: selected updates. J Thromb Haemost 2015; 13: S2.Google Scholar
Pigozzi, L, Aron, JP, Ball, J, et al. Understanding platelet dysfunction in sepsis. Intens Care Med 2016; 42: 583.Google Scholar
Rice, TW, Wheeler, AP. Coagulopathy in critically ill patient. Part 1: platelet disorders. Chest 2009; 136: 1622.Google Scholar
Sattler, FR, Weitekamp, MR, Ballard, JO. Potential for bleeding with the new beta-lactam antibiotics. Ann Intern Med 1986; 105: 924.Google Scholar
Schafer, AI. Bleeding and thrombosis in the myeloproliferative disorders. Blood 1984; 64: 1.Google Scholar
Yang, Z, Stulz, P, von Segesser, L, et al. Different interactions of platelets with arterial and venous coronary bypass vessels. Lancet 1991; 337: 939.Google Scholar
Bibliography
Bain, BJ. Ethnic and sex differences in the total and differential white cell count and platelet count. J Clin Pathol 1996; 49: 664.Google Scholar
Bombace, NM, Holmes, CE. The platelet contribution to cancer progression. J Thromb Haemost 2011; 9: 237.Google Scholar
Cognasse, F, Garraud, O, Pozzetto, B, et al. How can non-nucleated platelets be so smart? J Thromb Haemost 2016; 14: 794.Google Scholar
Handtke, S, Thiele, T. Large and small platelets — (when) do they differ? J Thromb Haemost 20020; 18: 1256.Google Scholar
Hoylaerts, MF, Vanassche, T, Verhamme, P. Bacterial killing by platelets; making sense of (H)IT. J Thromb Haemost 2018; 16: 1182.Google Scholar
Izzi, B, Bonaccio, M, De Gaetano, G, et al. Learning by counting blood platelets in population studies: survey and perspective a long way after Bizzozero. J Thromb Haemost 2018; 16: 1711.Google Scholar
Jurk, K, Kehrel, BE. Platelets: physiology and biochemistry. Semin Thromb Hemost 2005; 31: 381.Google Scholar
Koenen, RR. The prowess of platelets in immunity and inflammation. Thromb Haemost 2016; 116: 605.Google Scholar
Koupenova, M, Freedman, JE. Platelets: the unsung hero in the immune response. J Thromb Haemost 2015; 13: 268.Google Scholar
Pigozzi, L, Aron, JP, Ball, J, et al. Understanding platelet dysfunction in sepsis. Intens Care Med 2016; 42: 583.Google Scholar
Smyth, SS, McEver, RP, Weyrich, AS, et al. Platelet functions beyond hemostasis. J Thromb Haemost 2009; 7: 1759.Google Scholar
Bibliography
Agrawal, A, Palkar, A, Talwar, A. The multiple dimensions of platypnea-orthodeoxia syndrome: a review. Respir Med 2017; 129: 31.Google Scholar
Bibliography
Davignon, J. Beneficial cardiovascular pleiotropic effects of statins. Circulation 2004; 109: 39.Google Scholar
Bibliography
Belani, CP, ed. International symposium on thoracic malignancies. Chest 1998; 113 (suppl.): 1S.Google Scholar
Cagle, PT, Allen, TC. Pathology of the pleura: what the pulmonologists need to know. Respirolory 2011; 16: 430.Google Scholar
Lerner, AD, Feller-Kopman, D. Disorders of the pleura, mediastinum, and hilum. In: Scientific American Medicine. Pulmonary & Critical Care Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Matin, TN, Gleeson, FV. Interventional radiology of pleural diseases. Respirology 2011; 16: 419.Google Scholar
Bibliography
Alexandrakis, MG, Passam, FH, Kyriakou, DS, et al. Pleural effusions in hematologic malignancies. Chest 2004; 125: 1546.Google Scholar
Alfageme, I, Munoz, F, Pena, N, et al. Empyema of the thorax in adults: etiology, microbiologic findings, and management. Chest 1993; 103: 839.Google Scholar
Bartter, T, Santarelli, R, Akers, SM, et al. The evaluation of pleural effusion. Chest 1994; 106: 1209.Google Scholar
Bates, D, Yang, N, Bailey, M, et al. Prevalence, characteristics, drainage and outcome of radiologically diagnosed pleural effusions in critically ill patients. Crit Care Resusc 2020; 22: 45.Google Scholar
Brogi, E, Gargani, L, Bignami, E, et al. Thoracic ultrasound for pleural effusion in the intensive care unit: a narrative review from diagnosis to treatment. Crit Care 2017; 21: 325.Google Scholar
Cagle, PT, Allen, TC. Pathology of the pleura: what the pulmonologists need to know. Respirolory 2011; 16: 430.Google Scholar
Cerfolio, RJ, Allen, MS, Deschamps, C, et al. Postoperative chylothorax. J Thor Cardiovasc Surg 1996; 112: 1361.Google Scholar
Jamal, S, Maurer, JR. Pulmonary disease and the menstrual cycle. Pulmonary Perspectives 1994; 11(3): 3.Google Scholar
Joseph, J, Sahn, SA. Thoracic endometriosis syndrome: new observations from an analysis of 110 cases. Am J Med 1996; 100: 164.Google Scholar
Lerner, AD, Feller-Kopman, D. Disorders of the pleura, mediastinum, and hilum. In: Scientific American Medicine. Pulmonary & Critical Care Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Light, RW, MacGregor, MI, Luchsinger, PC, et al. Pleural effusions: the diagnostic separation of transudates and exudates. Ann Intern Med 1972; 77: 507.Google Scholar
Martinez, FJ, Villanueva, AG, Pickering, R, et al. Spontaneous hemothorax. Medicine 1992; 71: 354.Google Scholar
Matin, TN, Gleeson, FV. Interventional radiology of pleural diseases. Respirology 2011; 16: 419.Google Scholar
Romero, S, Candela, A, Martin, C, et al. Evaluation of different criteria for the separation of pleural transudates from exudates. Chest 1993; 104: 399.Google Scholar
Ryu, JH, Tomassetti, S, Maldonado, F. Update on uncommon pleural effusions. Respirology 2011; 16: 238.Google Scholar
Sahn, SA. Management of complicated parapneumonic effusions. Am Rev Respir Dis 1993; 148: 813.Google Scholar
Shiel, WC, Prete, PE. Pleuropulmonary manifestations of rheumatoid arthritis. Semin Arthritis Rheum 1984; 13: 235.Google Scholar
Taylor, JR, Ryu, J, Colby, TV, et al. Lymphangioleiomyomatosis. N Engl J Med 1990; 323: 1254.Google Scholar
Vaz, MA, Marchi, E, Vargas, FS. Cholesterol in the separation of transudates and exudates. Curr Opin Pulm Med 2001; 7: 183.Google Scholar
Walker-Renard, PB, Vaughan, LM, Sahn, SA. Chemical pleurodesis for malignant pleural effusions. Ann Intern Med 1994; 120: 56.Google Scholar
Bibliography
Cagle, PT, Allen, TC. Pathology of the pleura: what the pulmonologists need to know. Respirolory 2011; 16: 430.Google Scholar
Lerner, AD, Feller-Kopman, D. Disorders of the pleura, mediastinum, and hilum. In: Scientific American Medicine. Pulmonary & Critical Care Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Matin, TN, Gleeson, FV. Interventional radiology of pleural diseases. Respirology 2011; 16: 419.Google Scholar
Bibliography
Garland, SM, O’Reilly, MA. The risks and benefits of antimicrobial therapy in pregnancy. Drug Safety 1995; 13: 188.Google Scholar
Rigby, FB, Pastorek, JG. Pneumonia during pregnancy. Clin Obstet Gynecol 1996; 39: 107.Google Scholar
Riley, L. Pneumonia and tuberculosis in pregnancy. Infect Dis Clin North Am 1997; 11: 119.Google Scholar
Bibliography
Alifano, M, Roth, T, Broet, SC, et al. Catamenial pneumothorax: a prospective study. Chest 2003; 124: 1004.Google Scholar
Andrivet, P, Djedaini, K, Teboul, JL, et al. Spontaneous pneumothorax: comparison of thoracic drainage vs immediate or delayed needle aspiration. Chest 1995; 108: 335.Google Scholar
Baumann, MH, Strange, C. Treatment of spontaneous pneumothorax. A more aggressive approach? Chest 1997; 112: 789.Google Scholar
Baumann, MH, Strange, C. The clinician’s perspective on pneumothorax management. Chest 1997; 112: 822.Google Scholar
Baumann, MH, Strange, C, Heffner, JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi Consensus Statement. Chest 2001; 119: 590.Google Scholar
Chen, K-Y, Jerng, J-S, Liao, W-Y, et al. Pneumothorax in the ICU: patient outcomes and prognostic factors. Chest 2002; 122: 678.Google Scholar
Dugan, KC, Laxmanan, B, Murgu, S, et al. Management of persistent air leaks. Chest 2017; 152: 417.Google Scholar
Grotberg, JC, Hyzy, RC, De Cardenas, J, et al. Bronchopleural fistula in the mechanically ventilated patient: a concise review. Crit Care Med 2021; 49: 292.Google Scholar
Haynes, D, Baumann, MH. Pleural controversy: aetiology of pneumothorax. Respirology 2011; 16: 604.Google Scholar
Hazelrigg, SR. Secondary spontaneous pneumothorax: catamenial pneumothorax. Chest 2003; 124: 781.Google Scholar
Henry, M, Arnold, T, Harvey, J, et al. BTS guidelines for the management of spontaneous pneumothorax. Thorax 2003; 58 (suppl.): ii39.Google Scholar
Legras, A, Mansuet-Lupo, A, Rousset-Jablonski, C, et al. Pneumothorax in women of child-bearing age. Chest 2014; 145: 354.Google Scholar
Lerner, AD, Feller-Kopman, D. Disorders of the pleura, mediastinum, and hilum. In: Scientific American Medicine. Pulmonary & Critical Care Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Light, RW. Pleural controversy: optimal chest tube size for drainage. Respirology 2011; 16: 244.Google Scholar
Manaker, S. Circulating endometrial cells: a diagnostic test for distinguishing catamenial from spontaneous pneumothorax. Chest 2020; 157: 245.Google Scholar
Yarmus, L, Feller-Kopman, D. Pneumothorax in the critically ill patient. Chest 2012; 141: 1098.Google Scholar
Bibliography
Alapat, PM, Zimmerman, JL. Toxicology in the critical care unit. Chest 2008; 133: 1006.Google Scholar
Camporesi, EM. Use of hyperbaric oxygen in critical care. In: Lumb, PD, Shoemaker, WC, eds. Critical Care: State of the Art, Chapter 10. Fullerton: Society of Critical Care Medicine. 1990; p 219.Google Scholar
Chiew, AL, Reith, D, Pomerleau, A, et al. Updated guidelines for the management of paracetamol poisoning in Australia and New Zealand. Med J Aust 2020; 212: 175.Google Scholar
Kales, SN, Christiani, DC. Current concepts: acute chemical emergencies. N Engl J Med 2004; 350: 800.Google Scholar
Levine, M, Brooks, DE, Truitt, CA, et al. Toxicology in the ICU: part I, II & III. Chest 2011; 140: 795, 1072 & 1357.Google Scholar
Ling, L, Clark, RF, Erickson, T, et al., eds. Toxicology Secrets. Philadelphia; Hanley & Belfus. 2001.Google Scholar
Mokhlesi, B, Garinella, PS, Joffe, A, et al. Street drug abuse leading to critical illness. Intens Care Med 2004; 30: 1526.Google Scholar
Mokhlesi, B, Leiken, JB, Murray, P, et al. Adult toxicology in critical care: part I: general approach to the intoxicated patient. Chest 2003; 123: 577.Google Scholar
Mokhlesi, B, Leikin, JB, Murray, P, et al. Adult toxicology in critical care: part II: specific poisonings. Chest 2003; 123: 897.Google Scholar
Olson, KR, ed. Poisoning & Drug Overdose. 7th edition. New York: McGraw-Hill (Appleton & Lange). 2017.Google Scholar
Rosenstock, L, Cullen, M, Brodkin, C, et al., eds. Textbook of Clinical Occupational and Environmental Medicine. 2nd edition. Philadelphia: Saunders. 2004.Google Scholar
Shannon, MW, Borron, SW, Burns, MJ, eds. Haddad and Winchester’s Clinical Management of Poisoning and Drug Overdose. 4th edition. Philadelphia: WB Saunders. 2007.Google Scholar
True, B-L, Dreisbach, RH, eds. Dreisbach’s Handbook of Poisoning. Boca Raton: CRC Press. 2002.Google Scholar
Trujillo, MH, Guerrero, J, Fragachan, C, et al. Pharmacologic antidotes in critical care medicine: a practical guide for drug administration. Crit Care Med 1998; 26: 377.Google Scholar
Wiegand, TJ, Patel, MM, Olson, KR. Management of poisoning and drug overdose. In: Scientific American Medicine. Interdisciplinary Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Zimmerman, JL. Poisonings and overdoses in the intensive care unit: general and specific management issues. Crit Care Med 2003; 31: 2794.Google Scholar
Bibliography
Fine, PE, Griffiths, UK. Global poliomyelitis eradication: status and implications. Lancet 2007; 369: 1321.Google Scholar
Jiang, P, Faase, JA, Toyoda, H, et al. Evidence for emergence of diverse polioviruses from C-cluster coxsachie A viruses and implications for global poliovirus eradication. Proc Natl Acad Sci USA 2007; 104: 9204.Google Scholar
May, M, Durrheim, D, Roberts, JA, et al. The risks of medical complacency towards poliomyelitis. Med J Aust 2020; 213: 61.Google Scholar
Bibliography
Albert, DA, Rimon, D, Silverstein, MD. The diagnosis of poyarteritis nodosa. Arthritis Rheum 1988; 31: 1117.Google Scholar
Bibliography
Kidson, W. Polycystic ovary syndrome: a new direction in treatment. Med J Aust 1998; 169: 537.Google Scholar
Lobo, RA, Carmina, E. The importance of diagnosing the polycystic ovary syndrome. Ann Intern Med 2000; 132:989.Google Scholar
Norman, RJ, Wu, R, Stankiewixz, MT. Polycystic ovary syndrome. Med J Aust 2004; 180: 132.Google Scholar
Pal, L, Keefe, K. Polycystic ovary syndrome. In: Scientific American Medicine. Women’s Health. Hamilton: Dekker Medicine. 2020.Google Scholar
Shorakae, S, Boyle, J, Teede, H. Polycystic ovary syndrome: a common hormonal condition with major metabolic sequelae that physicians should know about. Intern Med J 2014; 44: 720.Google Scholar
Teede, HJ, Misso, ML, Deeks, AA, et al. Assessment and management of polycystic ovary syndrome: summary of an evidence-based guideline. Med J Aust 2011; 195 (suppl.): S65.Google Scholar
Bibliography
Broudy, VC. The polycythemias. In: Scientific American Medicine. Hematology. Hamilton: Dekker Medicine. 2020.Google Scholar
Campbell, PJ, Green, AR. The myeloproliferative disorders. N Engl J Med 2006; 355: 2452.Google Scholar
Challoner, T, Briggs, C, Rampling, MW, et al. A study of the haematological and haemorrheological consequences of venesection. Br J Haematol 1986; 62: 671.Google Scholar
Gareau, R, Audran, M, Barnes, R, et al. Erythropoietin abuse in athletes. Nature 1996; 380: 113.Google Scholar
Golde, DW, Hocking, WG, Koeffler, HP, et al. Polycythemia: mechanisms and management. Ann Intern Med 1981; 95: 71.Google Scholar
Gordeuk, VR, Sergueeva, AI, Miasnikova, GY, et al. Congenital disorder of oxygen sensing: association of the homozygous Chuvash polycythemia VHL mutation with thrombosis and vascular abnormalities but not tumors. Blood 2004; 103: 3924.Google Scholar
Gruppo Italiano Studio Policitemia. Polycythaemia vera. Ann Intern Med 1995; 123: 656.Google Scholar
Hinshelwood, S, Bench, AJ, Green, AR. Pathogenesis of polycythaemia vera. Blood Rev 1997; 11: 224.Google Scholar
Noakes, TD. Tainted glory: doping and athletic performance. N Engl J Med 2004; 351: 847.Google Scholar
Schafer, AI. Bleeding and thrombosis in myeloproliferative disorders. Blood 1984; 64: 1.Google Scholar
Bibliography
Hamilton, CR, Shelley, WM, Tumulty, PA. Giant cell arteritis: including temporal arteritis and polymyalgia rheumatica. Medicine 1971; 50: 1.Google Scholar
Hunder, GG, Bloch, DA, Michel, BA, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990; 33: 1122.Google Scholar
Owen, CE, Buchanan, RRC, Hoi, A. Recent advances in polymyalgia rheumatica. Intern Med J 2015; 45: 1102.Google Scholar
Zilko, PJ. Polymyalgia rheumatica and giant cell arteritis. Med J Aust 1996; 165: 438.Google Scholar
Bibliography
Dalakas, MC. Polymyositis, dermatomyositis, and inclusion-body myositis. N Engl J Med 1991; 325: 1487.Google Scholar
Fathi, M, Lundberg, IE. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol 2005; 17: 701.Google Scholar
Gerami, P, Schope, JM, McDonald, L, et al. A systematic review of adult-onset clinically amyopathic dermatomyositis (dermatomyositis sine myositis): a missing link within the spectrum of the idiopathic inflammatory myopathies. J Am Acad Dermatol 2006; 54: 597.Google Scholar
Limaye, VS, Blumbergs, P, Roberts-Thomson, PJ. Idiopathic inflammatory myopathies. Intern Med J 2009; 39: 179.Google Scholar
Marie, I, Hatron, PY, Levesque, H, et al. Influence of age on characteristics of polymyositis and dermatomyositis in adults. Medicine 1999; 78: 139.Google Scholar
Miller, FW. Classification and prognosis of inflammatory muscle disease. Rheum Dis Clin North Am 1994; 20: 811.Google Scholar
Sigurgeirsson, B, Lindelof, B, Edhag, O, et al. Risk of cancer in patients with dermatomyositis or polymyositis. N Engl J Med 1992; 326: 363.Google Scholar
Tazelaar, HD, Viggiano, RW, Pickersgill, J, et al. Interstitial lung disease in polymyositis and dermatomyositis: clinical features and prognosis as correlated with histologic findings. Am Rev Resp Dis 1990; 141: 727.Google Scholar
Bibliography
Anderson, KE, Bloomer, JR, Bonkovsky, H, et al. Recommendations for the diagnosis and treatment of the acute porphyrias. Ann Intern Med 2005; 142: 439.Google Scholar
Anderson, KE, Kappas, A. The porphyrias. In: Scientific American Medicine. Endocrinology & Metabolism. Hamilton: Dekker Medicine. 2020.Google Scholar
Brodie, MJ, Moore, MR, Thompson, GG, et al. Pregnancy and the acute porphyrias. Br J Obstet Gynaec 1977; 84: 726.Google Scholar
Kauppinen, R, Mustajoki, P. Prognosis of acute porphyria: occurrence of acute attacks, precipitating factors, and associated diseases. Medicine 1992; 71: 1.Google Scholar
Lamon, JM, Bennett, M, Frykholm, BC, et al. Prevention of acute porphyric attacks by intravenous haematin. Lancet 1978; 2: 492.Google Scholar
Mustajoki, P, Heinonen, J. General anesthesia in ‘inducible’ porphyrias. Anesthesiology 1980; 53: 15.Google Scholar
Mustajoki, P, Nordman, Y. Early administration of heme arginate for acute porphyric attacks. Arch Intern Med 1993; 153: 2004.Google Scholar
Ratnaike, S, Blake, D, Campbell, D, et al. Plasma ferritin levels as a guide to the treatment of porphyria cutanea tarda by venesection. Aust J Dermatol 1988; 29: 3.Google Scholar
Yeung Laiwah, AC, Moore, MR, Goldberg, A. Pathogenesis of acute porphyria. Quart J Med 1987; 63: 377.Google Scholar
Bibliography
Arbogast, BW, Taylor, RN. Molecular Mechanisms of Pre-eclampsia. Berlin: Springer-Verlag. 1997.Google Scholar
Bucher, HC, Guyatt, GH, Cook, RJ, et al. Effect of calcium supplementation on pregnancy-induced hypertension and preeclampsia. A meta-analysis of randomised controlled trials. JAMA 1996; 275: 1113.Google Scholar
Chua, S, Redman, CWG. Are prophylactic anticonvulsants required in severe pre-eclampsia? Lancet 1991; 337: 250.Google Scholar
CLASP (Collaborative Low-dose Aspirin Study in Pregnancy) Collaborative Group. CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women. Lancet 1994; 343: 619.Google Scholar
Cunningham, FG, Grant, NF. Prevention of preeclampsia – a reality? N Engl J Med 1989; 321: 606.Google Scholar
Davison, JM, Shiells, EA, Barron, WM, et al. Changes in the metabolic clearance of vasopressin and plasma vasopressinase throughout human pregnancy. J Clin Invest 1989; 83: 1313.Google Scholar
Dekker, GA, Sibai, B. Primary, secondary, and tertiary prevention of pre-eclampsia. Lancet 2001; 357: 209.Google Scholar
Durr, JA, Hoggard, JG, Hunt, JM, et al. Diabetes insipidus in pregnancy associated with abnormally high circulating vasopressinase activity. N Engl J Med 1987; 316: 1070.Google Scholar
Gant, NF, Worley, RJ, Everett, RB, et al. Control of vascular responsiveness during human pregnancy. Kidney Int 1980; 18: 253.Google Scholar
Higby, Suiter CR, Phelps, JY, et al. Normal values of urinary albumin and total protein excretion during pregnancy. Am J Obstet Gynecol 1994; 171: 984.Google Scholar
Hod, T, Cerdeira, AS, Karumanchi, SA. Molecular mechanisms of preeclampsia. Cold Spring Harb Perspect Med 2015; 5: a023473.Google Scholar
Ihle, BU, Long, P, Oats, J. Early onset pre-eclampsia: recognition of underlying renal disease. BMJ 1987; 294: 79.Google Scholar
Leone, M, Einav, S. Severe preeclampsia: what’s new in intensive care? Intens Care Med 2015; 41: 1343.Google Scholar
Lucas, MJ, Leveno, KJ, Cunningham, FG. A comparison of magnesium sulfate with phenytoin for the prevention of eclampsia. N Engl J Med 1995; 333: 201.Google Scholar
Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomized placebo controlled trial. Lancet 2002; 359: 1877.Google Scholar
Martin, JN, Files, FC, Blake, PG. Plasma exchange for preeclampsia: I. Postpartum use for persistently severe preeclampsia with HELLP syndrome. Am J Obstet Gynecol 1990; 162: 126.Google Scholar
Myatt, L, Webster, RP. Vascular biology of preeclampsia. J Thromb Haemost 2009; 7: 375.Google Scholar
Need, JA. Pre-eclampsia in pregnancies by different fathers: immunological studies. BMJ 1975; 1: 548.Google Scholar
Perry, KG, Martin, JN. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia. Clin Obstet Gynecol 1992; 35: 338.Google Scholar
Roberts, J, Taylor, R, Goldfen, A. Clinical and biochemical evidence of endothelial cell dysfunction in pregnancy syndrome eclampsia. Am J Hypertens 1991; 4: 700.Google Scholar
Sibai, BM, El-Nazer, A, Gonzalez-Ruiz, A. Severe preeclampsia in young primigravid women: subsequent pregnancy outcome and remote prognosis. Am J Obstet Gynecol 1986; 155: 1011.Google Scholar
The Eclampsia Trial Collaborative Group. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 1995; 345: 1455.Google Scholar
Williams, DJ, de Swiet, M. The pathophysiology of pre-eclampsia. Intens Care Med 1997; 23: 620.Google Scholar
Bibliography
Arnout, J, Spitz, B, Wittevrongel, C, et al. High-dose intravenous immunoglobulin treatment of a pregnant patient with an antiphospholipid syndrome. Thromb Haemost 1994; 71: 741.Google Scholar
Australian Society for the Study of Hypertension in Pregnancy. Management of hypertension in pregnancy: consensus statement. Med J Aust 1993; 158: 700.Google Scholar
Barron, WM. The pregnant surgical patient: medical evaluation and management. Ann Intern Med 1984; 101: 683.Google Scholar
Bates, SM, Greer, IA, Pabinger, I, et al. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy. Chest 2008; 133 (suppl.): 844S.Google Scholar
Battino, D, Granata, T, Binelli, S, et al. Intrauterine growth in the offspring of epileptic mothers. Acta Neurol Scand 1992; 86: 555.Google Scholar
Beeley, L. Adverse effects of drugs in later pregnancy. Clin Obstet Gynaecol 1981; 24: 275.Google Scholar
Bick, RL. Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: prevalence, treatment and outcome results. Clin Appl Thromb Hemost 2000; 6: 115.Google Scholar
Branch, DW, Scott, JR, Kochenour, NK, et al. Obstetric complications associated with the lupus anticoagulant. N Engl J Med 1985; 313: 1322.Google Scholar
Brenner, B, Conard, J, eds. Women’s issues in thrombophilia. Semin Thromb Hemost 2003; 29: 1.Google Scholar
Briggs, GG, Freeman, RL, Towers, CV, et al., eds. Drugs in Pregnancy and Lactation. 11th edition. Philadelphia: Lippincott Williams & Wilkins. 2017.Google Scholar
Brodie, MJ, Moore, MR, Thompson, GG, et al. Pregnancy and the acute porphyrias. Br J Obstet Gynaec 1977; 84: 726.Google Scholar
Brooks, DC, Sznyter, LA. Pregnancy. In: Scientific American Surgery, Section VII Special Problems in Perioperative Care, Chapter 11. New York: Scientific American. 1998.Google Scholar
Brown, M, Whitworth, J. The kidney in hypertensive pregnancies – victim and villain. Am J Kidney Dis 1992; 20: 427.Google Scholar
Brown, MA, Buddle, ML. Hypertension in pregnancy: maternal and foetal outcomes according to laboratory and clinical features. Med J Aust 1996; 165: 360.Google Scholar
Burrow, GN. The management of thyrotoxicosis in pregnancy. N Engl J Med 1985; 313: 562.Google Scholar
Cheah, S, Gao, Y, Mo, S, et al. Fertility, pregnancy and post partum management after bariatric surgery: a narrative review. Med J Aust 2022; 216: 96.Google Scholar
Chestnut, DH. Critical care in obstetric practice. In: Fuhrman, BP, Shoemaker, WC, eds. Critical Care: State of the Art, Chapter 7. Fullerton: Society of Critical Care Medicine. 1989; 121.Google Scholar
Council on Scientific Affairs, American Medical Association. Fetal effects of maternal alcohol use. JAMA 1983; 249: 2517.Google Scholar
Cowchock, FS, Reece, EA, Balaban, D, et al. Repeated fetal losses associated with antiphospholipid antibodies. Am J Obstet Gynecol 1992; 166: 1318.Google Scholar
Dansky, LV, Rosenblatt, DS, Andermann, E. Mechanisms of teratogenesis: folic acid and antiepileptic therapy. Neurology 1992; 42 (suppl. 5): 32.Google Scholar
Fildes, J, Reed, L, Jones, N, et al. Trauma: the leading cause of maternal death. J Trauma 1992; 32: 643.Google Scholar
Ginsberg, JS, Bates, SM. Management of venous thromboembolism during pregnancy. J Thromb Haemost 2003; 1: 1435.Google Scholar
Ginsberg, JS, Brill-Edwards, P, Johnston, M, et al. Relationship of antiphospholipid antibodies to pregnancy loss in patients with systemic lupus erythematosus. Blood 1992; 80: 975.Google Scholar
Ginsberg, JS, Hirsh, J. Use of antithrombotic agents during pregnancy. Chest 1992; 102 (suppl. 4): 385S.Google Scholar
Greer, IA. Thrombosis in pregnancy: maternal and foetal issues. Lancet 1999; 353: 1258.Google Scholar
Grunfeld, J-P, Pertuiset, N. Acute renal failure in pregnancy. Am J Kidney Dis 1987; 9: 359.Google Scholar
Guntupalli, KK, Hall, N, Karnad, DR, et al. Critical illness in pregnancy. Chest 2015; 148: 1093 & 1333.Google Scholar
Hanly, JG, Gladman, DD, Rose, TH, et al. Lupus pregnancy: a prospective study of placental changes. Arthritis Rheum 1988; 31: 358.Google Scholar
Hazelgrove, JF, Price, C, Pappachan, VJ, et al. Multicenter study of obstetric admissions to 14 intensive care units in southern England. Crit Care Med 2001; 29: 770.Google Scholar
Henriquez, DDCA, Bloemenkamp, KWM, Van Der Bom, JG. Management of postpartum haemorrhage: how to improve maternal outcomes? Thromb Haemost 2018; 16: 1523.Google Scholar
Hiilesmaa, VK. Pregnancy and birth in women with epilepsy. Neurology 1992; 42 (suppl. 5): 8.Google Scholar
Horowitz, MD, Gomez, GA, Santiesteban, R, et al. Acute appendicitis during pregnancy. Arch Surg 1985; 120: 1362.Google Scholar
Imperiale, TF, Petrulis, AS. A meta-analysis of low-dose aspirin for the prevention of pregnancy-induced hypertensive disease. JAMA 1991; 266: 237.Google Scholar
Johns, KR, Morand, EF, Littlejohn, GO. Pregnancy outcome in systemic lupus erythematosus. Aust NZ J Med 1998; 28: 18.Google Scholar
Johnson, MJ. Obstetric complications and rheumatic disease. Rheum Dis Clin North Am 1997; 23: 169.Google Scholar
Jones, WB, Lewis, JL. Integration of surgery and other techniques in the management of trophoblastic malignancy. Obstet Gynecol Clin North Am 1988; 15: 565.Google Scholar
Kaaja, E, Kaaja, R, Hiilesmaa, V. Major malformations in offspring of women with epilepsy. Neurology 2003; 50: 575.Google Scholar
Kjellberg, U, Andersson, N-E, Rosen, S, et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527.Google Scholar
Koch, S, Losche, G, Jager-Roman, E, et al. Major and minor birth malformations and antiepileptic drugs. Neurol 1992; 42 (suppl. 5): 83.Google Scholar
Koshy, M, Burd, L. Management of pregnancy in sickle cell anemia. Hematol Oncol Clin North Am 1991; 5: 585.Google Scholar
Lapinsky, SE. Respiratory care of the critically ill pregnant patient. Curr Opin Crit Care 1996; 3: 1.Google Scholar
Lapinsky, SE. Cardiopulmonary complications of pregnancy. Crit Care Med 2005; 33: 1616.Google Scholar
Laskin, CA, Bombardier, C, Hannah, ME. Prednisolone and aspirin in women with autoantibodies and unexplained recurrent fetal loss. N Engl J Med 1997; 337: 148.Google Scholar
Leung, AS, Millar, LK, Koonings, PP, et al. Perinatal outcome in hypothyroid pregnancies. Obstet Gynecol 1993; 81: 349.Google Scholar
Lim, V, Katz, A, Lindheimer, M. Acid-base regulation in pregnancy. Am J Physiol 1976; 231: 1764.Google Scholar
Loverro, G, Pansini, V, Greco, P, et al. Indications and outcome for intensive care unit admission during puerperium. Arch Gynecol Obstet 2002; 265: 195.Google Scholar
McDonald, CF, Burdon, JGW. Asthma in pregnancy and lactation: a position paper for the Thoracic Society of Australia and New Zealand. Med J Aust 1996; 165: 485.Google Scholar
McPartin, J, Halligan, A, Scott, JM, et al. Accelerated folate breakdown in pregnancy. Lancet 1993; 341: 148.Google Scholar
Oats, JJN (chairman). Annual Report for the Year 2007. Melbourne: Consultative Council on Obstetric and Paediatric Mortality and Morbidity. 2008.Google Scholar
Persellin, RH. The effect of pregnancy on rheumatoid arthritis. Bull Rheum Dis 1977; 27: 922.Google Scholar
Phelan, JP, Pacheco, LD, Foley, MR, et al., eds. Critical Care Obstetrics. 6th edition. Oxford: Wiley. 2018.Google Scholar
Pisani, RJ, Rosenow, EC. Pulmonary edema associated with tocolytic therapy. Ann Intern Med 1989; 110: 714.Google Scholar
Pollock, W, Rose, L, Dennis, C-L. Pregnant and postpartum admissions to the intensive care unit: a systematic review. Intens Care Med 2010; 36: 1465.Google Scholar
Rabinovich, A, Abdul-Kadir, R, Thachil, J, et al. DIC in obstetrics: Diagnostic score, highlights in management, and international registry – communication from the DIC and Women’s Health SSCs of the International Society of Thrombosis and Haemostasis. J Thromb Haemost 2019; 17: 1562.Google Scholar
Rand, JH, Wu, X-X, Andree, HAM, et al. Pregnancy loss in the antiphospholipid-antibody-syndrome – a possible thrombogenic mechanism. N Engl J Med 1997; 337: 154.Google Scholar
Rizk, NW, Kalassian, KG, Gilligan, T, et al. Obstetric complications in pulmonary and critical care medicine. Chest 1996; 110: 791.Google Scholar
Sanson, B-J, Lensing, AWA, Prins, MH, et al. Safety of low-molecular-weight heparin in pregnancy: a systematic review. Thromb Haemost 1999; 81: 668.Google Scholar
Schrier, RW. Pathogenesis of sodium and water retention in high-output and low-output cardiac failure, nephrotic syndrome, cirrhosis, and pregnancy. N Engl J Med 1988; 319: 1065 & 1127.Google Scholar
Seely, EW, Ecker, J. Medical complications in pregnancy. In: Scientific American Medicine. Women’s Health. Hamilton: Dekker Medicine. 2020.Google Scholar
Smith, A, Eccles-Smith, J, D’Emden, M, et al. Thyroid disorders in pregnancy and postpartum. Aust Prescriber 2017; 40: 214.Google Scholar
Therapeutic Goods administration. Prescribing medicines in pregnancy database. www.tga.gov.au/mode/4012. 2019.Google Scholar
Vasquez, DN, Estenssoro, E, Canales, HS, et al. Clinical characteristics and outcomes of obstetric patients requiring ICU admission. Chest 2007; 131: 718.Google Scholar
Wald, NJ, Bower, C. Folic acid, pernicious anaemia, and prevention of neural tube defects. Lancet 1994; 343: 307.Google Scholar
Yerby, M, Koepsell, T, Darling, J. Pregnancy complications and outcomes in a cohort of women with epilepsy. Epilepsia 1985; 26: 631.Google Scholar
Yerby, MS, Friel, PN, McCormick, K. Antiepileptic drug disposition during pregnancy. Neurology 1992; 42 (suppl. 5): 12.Google Scholar
Yerby, MS, Leavitt, A, Erickson, DM, et al. Antiepileptics and the development of congenital anomalies. Neurology 1992; 42 (suppl. 5): 132.Google Scholar
Zeeman, GG. Obstetric critical care: a blueprint for improved outcomes. Crit Care Med 2006; 34 (suppl.): S208.Google Scholar
Zwart, JJ, Dupuis, JRO, Richters, A, et al. Obstetric intensive care unit admission: a 2-year nationwide population-based cohort study. Intens Care Med 2010; 36: 256.Google Scholar
Bibliography
Hodgson, D. Of gods and leeches: treatment of priapism in the nineteenth century. J R Soc Med 2003; 96: 562.Google Scholar
Pautler, SE, Brock, GB. Priapism: from Priapus to the present time. Urol Clin North Am 2001; 28: 391.Google Scholar
Bibliography
Corbelli, R, Bringolf-Isler, B, Amacher, A, et al. Nasal nitric oxide measurements to screen for primary ciliary dyskinesia. Chest 2004; 126: 1054.Google Scholar
Horani, A, Ferkol, TW. Advances in the genetics of primary ciliary dyskinesia: clinical implications. Chest 2018; 154: 645.Google Scholar
Kennedy, MP, Noone, PG, Cardon, J, et al. Calcium stone lithoptysis in primary ciliary dyskinesia. Respir Med 2007; 101: 76.Google Scholar
Marthin, JK, Mortensen, J, Pressler, T, et al. Pulmonary radioaerosol mucociliary clearance in diagnosis of primary ciliary dyskinesia. Chest 2007; 132: 966.Google Scholar
Mygind, N, Nielsen, MH, Pedersen, M. Kartagener’s syndrome and abnormal cilia. Eur J Respir Dis 1983; 64 (suppl. 127): 1.Google Scholar
Noone, PG, Leigh, MW, Sannuti, A, et al. Primary ciliary dyskinesia: diagnostic and phenotypic features. Am J Respir Crit Care Med 2004; 169: 459.Google Scholar
Bibliography
Hempel, S, Newberry, SJ, Maher, AR, et al. Probiotics for the prevention and treatment of antibiotic-associated diarrhea: a systematic review and meta-analysis. JAMA 2012; 307: 1959.Google Scholar
Ho, KM, Kalgudi, S, Corbett, J-M, et al. Gut microbiota in surgical and critically ill patients. Anaesth Intens Care 2020; 48: 179.Google Scholar
Johnstone, J, Meade, M, Lauzier, F, et al. Effect of probiotics on incident ventilator-associated pneumonia in critically ill patients: a randomized clinical trial. JAMA 2021; 326: 1024.Google Scholar
Manzanares, W, Lemieux, M, Langlois, PL, et al. Probiotic and synbiotic therapy in critical illness: a systematic review and meta-analysis. Crit Care 2016; 19: 262.Google Scholar
Morrow, LE, Wischmeyer, P. Blurred lines: dysbiosis and probiotics in the ICU. Chest 2017; 151: 492.Google Scholar
Bibliography
Chukwuemeka, A, Ko, R, Ralph-Edwards, A. Short-term low-dose propofol anaesthesia associated with severe metabolic acidosis. Anaesth Intens Care 2006; 34: 651.Google Scholar
De Waele, JJ, Hoste, E. Propofol infusion syndrome in a patient with sepsis. Anaesth Intens Care 2006; 34: 676.Google Scholar
Ernest, D, French, C. Propofol infusion syndrome – report of an adult fatality. Anaesth Intens Care 2003; 31: 316.Google Scholar
Fudickar, A, Bein, B, Tonner, PH. Propofol infusion syndrome in anaesthesia and intensive care medicine. Curr Opin Anaesthesiol 2006; 19: 404.Google Scholar
Hempill, S, McMenamin, L, Bellamy, MC, et al. Propofol infusion syndrome: a structured literature review and analysis of published case reports. Br J Anaesth 2019; 122: 448.Google Scholar
Iyer, VN, Hoel, R, Rabinstein, AA. Propofol infusion syndrome in patients with refractory status epilepticus: an 11-year clinical experience. Crit Care Med 2009; 37: 3024.Google Scholar
Krajcova, A, Waldauf, P, Andel, M, et al. Propofol infusion syndrome: a structured review of experimental studies and 153 published case reports. Crit Care 2015; 19: 398.Google Scholar
Masuda, A, Hirota, K, Satone, T, et al. Pink urine during propofol anesthesia. Anesth Analg 1996; 83: 666.Google Scholar
Mizock, BA, Falk, JL. Lactic acidosis in critical illness. Crit Care Med 1992; 20: 80.Google Scholar
Riker, RR, Glisic, EK, Fraser, GL. Propofol infusion syndrome: difficult to recognize, difficult to study. Crit Care Med 2009; 37: 3169.Google Scholar
Vasile, B, Rasulo, F, Candiani, A, et al. The pathophysiology of propofol infusion syndrome: a simple name for a complex syndrome. Intens Care Med 2003; 29: 1417.Google Scholar
Bibliography
Bernard, GR, Vincent, J-L, Laterre, P-F, et al. Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001; 344: 699.Google Scholar
Bertina, RM, Koeleman, RPC, Koster, T, et al. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64.Google Scholar
Castoldi, E, Rosing, J. APC resistance: biological basis and acquired influences. J Thromb Haemost 2009; 8: 445.Google Scholar
Dhainaut, J-F, Aird, WC, Esmon, CT, eds. Protein C pathways: bedside to bench. Crit Care Med 2004; 32; suppl.Google Scholar
Dowd, P, Ham, S-W, Naganathan, S, et al. The mechanism of action of vitamin K. Annu Rev Nutr 1995; 15: 419.Google Scholar
Esmon, CT, Johnson, AE, Esmon, NL, et al. Initiation of the protein C pathway. Ann NY Acad Sci 1991; 614: 30.Google Scholar
Kisiel, W. Human plasma protein C: isolation, characterization and mechanism of activation by alpha-thrombin. J Clin Invest 1979; 64: 761.Google Scholar
Kjellberg, U, Andersson, N-E, Rosen, S, et al. APC resistance and other haemostatic variables during pregnancy and puerperium. Thromb Haemost 1999; 81: 527.Google Scholar
Koster, T, Rosendaal, FR, de Ronde, H, et al. Venous thrombosis due to poor anticoagulant response to activated protein C. Lancet 1993; 342: 1503.Google Scholar
Mannucci, PM, Franchini, M. Classic thrombophilic gene variants. Thromb Haemost 2015; 114: 885.Google Scholar
Matsuzaka, T, Tanaka, H, Fukuda, M, et al. Relationship between vitamin K dependent coagulation factors and anticoagulants (protein C and protein S) in neonatal vitamin K deficiency. Arch Dis Child 1993; 68: 297.Google Scholar
Papinger, I, Kyrle, PA, Heistinger, M, et al. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency. Thromb Haemost 1994; 71: 441.Google Scholar
Rodeghiero, F, Tosetto, A. Activated protein C resistance and factor V Leiden mutation are independent risk factors for venous thromboembolism. Ann Intern Med 1999; 130: 643.Google Scholar
Rose, VL, Kwaan, HC, Williamson, K, et al. Protein C antigen deficiency and warfarin necrosis. Am J Clin Pathol 1986; 86: 653.Google Scholar
Smith, OP, White, B, Vaughan, D, et al. Use of protein C concentrate, heparin, and haemodiafiltration in meningococcus-induced purpura fulminans. Lancet 1997; 350: 1590.Google Scholar
Svensson, PJ, Dahlback, B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517.Google Scholar
Yan, SB, Helterbrand, JD, Hartman, DL, et al. Low levels of protein C are associated with poor outcome in severe sepsis. Chest 2001; 120: 915.Google Scholar
Zoller, B, Hillarp, A, Dahlback, B. Activated protein C resistance: Clinical implications. Clin Appl Thromb Hemost 1997; 3: 25.Google Scholar
Bibliography
Borgel, D, Gandrille, S, Aiach, M. Protein S deficiency. Thromb Haemost 1997; 78: 351.Google Scholar
Comp, PC. Laboratory evaluation of protein S status. Semin Thromb Haemost 1990; 16: 177.Google Scholar
Comp, PC, Esmon, CT. Recurrent venous thromboembolism in patients with a partial deficiency of protein S. N Engl J Med 1984; 311: 1525.Google Scholar
Dahlback, B. Vitamin K-dependent protein S: beyond the protein C pathway. Semin Thromb Hemost 2018; 44: 176.Google Scholar
Dowd, P, Ham, S-W, Naganathan, S, et al. The mechanism of action of vitamin K. Annu Rev Nutr 1995; 15: 419.Google Scholar
Engesser, L, Broekmans, AW, Briet, E, et al. Hereditary protein S deficiency: clinical manifestations. Ann Intern Med 1987; 106: 677.Google Scholar
Gierula, M, Ahnstrom, J. Anticoagulant protein S – new insights on interactions and functions. J Thromb Haemost 2020; 18: 2801.Google Scholar
Mannucci, PM, Franchini, M. Classic thrombophilic gene variants. Thromb Haemost 2015; 114: 885.Google Scholar
Matsuzaka, T, Tanaka, H, Fukuda, M, et al. Relationship between vitamin K dependent coagulation factors and anticoagulants (protein C and protein S) in neonatal vitamin K deficiency. Arch Dis Child 1993; 68: 297.Google Scholar
Papinger, I, Kyrle, PA, Heistinger, M, et al. The risk of thromboembolism in asymptomatic patients with protein C and protein S deficiency. Thromb Haemost 1994; 71: 441.Google Scholar
Bibliography
Bibliography
Gosling, P, Czyz, J, Nightingale, P, et al. Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit Care Med 2006; 34: 2158.Google Scholar
Robinson, RR. Isolated proteinuria in asymptomatic patients. Kidney Int 1980; 18: 395.Google Scholar
Turner, NN, Lameire, N, Goldsmith, DJ, et al. eds. Oxford Textbook of Clinical Nephrology. 4th edition. Oxford: Oxford University Press. 2015.Google Scholar
Bibliography
Poort, SR, Rosendaal, FR, Reitsma, PH, et al. A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 1996; 88: 3698.Google Scholar
Bibliography
Van Voorhis, WC. Protozoan infections. In: Scientific American Medicine. Infectious Disease. Hamilton: Dekker Medicine. 2020.Google Scholar
Bibliography
Bibliography
Greenberg, S, Reiser, IW, Chou, SY, et al. Trimethoprim-sulfamethoxazole induces reversible hyperkalemia. Ann Intern Med 1993; 119: 291.Google Scholar
Bibliography
Bonventre, JV, Leaf, A. Sodium homeostasis: steady states without a set point. Kidney Int 1982; 21: 880.Google Scholar
Dixon, B, Ernest, D. Hyponatraemia in the transurethral resection of prostate syndrome. Anaesth Intens Care 1996; 24: 102.Google Scholar
Spasovski, G, Vanholder, R, Allolio, B, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Intens Care Med 2014; 40: 320.Google Scholar
Bibliography
Moran, BJ, Cecil, TD. The etiology, clinical presentation, and management of pseudomyxoma peritonei. Surg Oncol Clin N Am 2003; 12: 585.Google Scholar
Bibliography
Ponec, RJ, Saunders, MD, Kimmey, MB. Neostigmine for the treatment of acute colonic pseudo-obstruction. N Engl J Med 1999; 341: 137.Google Scholar
Bibliography
Kaplan, RM. Budgies and bugs: our homegrown contribution to pandemics. Med J Aust 2021; 214: 509.Google Scholar
Bibliography
Abel, EA, Lebwohl, M. Psoriasis. In: Scientific American Medicine. Dermatology. Hamilton: Dekker Medicine. 2020.Google Scholar
Calvert, HT, Smith, MA, Wells, RS. Psoriasis and the nails. Br J Dermatol 1963; 75: 415.Google Scholar
Dawe, RS, Cameron, H, Yule, S, et al. UV-B phototherapy clears psoriasis through local effects. Arch Dermatol 2002; 138: 1071.Google Scholar
Farber, EM, Nall, ML. The natural history of psoriasis in 5,600 patients. Dermatologica 1974; 148: 1.Google Scholar
Farber, EM, Nall, ML. An appraisal of measures to prevent and control psoriasis. J Am Acad Dermatol 1992; 26: 736.Google Scholar
Fox, BJ, Odom, RB. Papulosquamous diseases: a review. J Am Acad Dermatol 1985; 12: 597.Google Scholar
Kovitwanichkanont, T, Chong, AH, Foley, P. Beyond skin deep: addressing comorbidities in psoriasis. Med J Aust 2020; 212: 528.Google Scholar
Smith, D. Fumaric acid esters for psoriasis: a systematic review. Ir J Med Sci 2017; 186: 161.Google Scholar
Whyte, HJ, Baughman, RD. Acute guttate psoriasis and streptococcal infection. Arch Dermatol 1964; 89: 350.Google Scholar
Wolff, K, Goldsmith, L, Katz, S, et al., eds. Fitzpatrick’s Dermatology in General Medicine. 7th edition. New York: McGraw-Hill. 2007.Google Scholar
Bibliography
Bienvenu, OJ, Neufeld, KJ, Needham, DM. Treatment of four psychiatric emergencies in the intensive care unit. Crit Care Med 2012; 40: 2662.Google Scholar
Black, DW, ed. Psychiatry. In: Scientific American Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Cucci, MD, Chester, KW, Hamilton, LA. Concise definitive review for reinitiation of antidepressants, antipsychotics, and gabapentinoids in ICU patients. Crit Care Med 2022; 50: 665.Google Scholar
Bibliography
Claypool, WD, Rogers, RM, Matuschak, GM. Update on the clinical diagnosis, management, and pathogenesis of pulmonary alveolar proteinosis (phospholipidosis). Chest 1984; 85: 550.Google Scholar
Goldstein, LS, Kavuru, MS, Curtis-McCarthy, P, et al. Pulmonary alveolar proteinosis: clinical features and outcome. Chest 1998; 114: 1357.Google Scholar
Greenhill, SR, Kotton, DN. Pulmonary alveolar proteinosis: a bench-to-bedside story of granulocyte-macrophage colony-stimulating factor dysfunction. Chest 2009; 136: 571.Google Scholar
Jouneau, S, Menard, C, Lederlin, M. Pulmonary alveolar proteinosis. Respirology 2020; 10: 1111.Google Scholar
Michaud, G, Reddy, C, Ernst, A. Whole-lung lavage for pulmonary alveolar proteinosis. Chest 2009; 136: 1678.Google Scholar
Rosen, SH, Castleman, B, Liebow, AA. Pulmonary alveolar proteinosis. N Engl J Med 1958: 258: 1123.Google Scholar
Seymour, JF, Presneill, JJ. Pulmonary alveolar proteinosis: progress in the first 44 years. Am J Respir Crit Care Med 2002; 166: 215.Google Scholar
Seymour, JF, Presneill, JJ, Schoch, OD, et al. Therapeutic efficacy of granulocyte-macrophage colony-stimulating factor in patients with idiopathic acquired alveolar proteinosis. Am J Respir Crit Care Med 2001; 163: 531.Google Scholar
Trapnell, BC, Whitsett, JA, Nakata, K. Pulmonary alveolar proteinosis. N Engl J Med 2003; 349: 2527.Google Scholar
Bibliography
Auger, WR, Channick, RN, Kerr, KM, et al. Evaluation of patients with suspected chronic thromboembolic pulmonary hypertension. Semin Thorac Cardiovasc Surg 1999; 11: 179.Google Scholar
Badesch, DB, Abman, SH, Simonneau, G, et al. Medical therapy for pulmonary arterial hypertension: updated ACCP evidence-based clinical practice guidelines. Chest 2007; 131: 1917.Google Scholar
Barst, RJ, Rubin, LJ, Long, WA, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996; 334: 296.Google Scholar
Bauer, M, Fuhrmann, V, Wendon, J. Pulmonary complications of liver disease. Intens Care Med 2019; 45: 1433.Google Scholar
Budhiraja, R, Hassoun, PM. Portopulmonary hypertension: a tale of two circulations. Chest 2003; 123: 562.Google Scholar
Chin, KM, Channick, RN, Rubin, LJ. Is methamphetamine use associated with idiopathic pulmonary arterial hypertension? Chest 2006; 130: 1657.Google Scholar
Dantzker, DR, Grant, BJB. Pulmonary hypertension. In: Shoemaker, WC, Thompson, WL, eds. Critical Care: State of the Art. Fullerton: Society of Critical Care Medicine. 1983; p F1.Google Scholar
Dartrevelle, P, Fadel, E, Mussor, S, et al. Chronic thromboembolic pulmonary hypertension. Eur Respir J 2004; 23: 637.Google Scholar
Farber, HW, Loscalzo, J. Pulmonary arterial hypertension N Engl J Med 2004; 351: 1655.Google Scholar
Fedullo, PF, Auger, WR, Kerr, KM, et al. Chronic thromboembolic pulmonary hypertension. N Engl J Med 2001; 345: 1465.Google Scholar
Fishman, AP. Clinical classification of pulmonary hypertension. Clin Chest Med 2001; 22: 385.Google Scholar
Gabbay, E, Reed, A, Williams, TJ. Assessment and treatment of pulmonary arterial hypertension. Intern Med J 2007; 37: 38.Google Scholar
Hemnes, AR, Opotowsky, AR, Assad, TR, et al. Features associated with discordance between pulmonary arterial wedge pressure and left ventricular end diastolic pressure in clinical practice: implications for pulmonary hypertension classification. Chest 2019; 154: 1099.Google Scholar
Humbert, M, Sitbon, O, Simonneau, G. Treatment of pulmonary arterial hypertension. N Engl J Med 2004; 351: 1425.Google Scholar
Keogh, AM, McNeil, KD, Williams, T, et al. Pulmonary arterial hypertension: a new era in management. Med J Aust 2003; 178: 564.Google Scholar
Klinger, JR, Elliott, CG, Levine, DJ, et al. Therapy for pulmonary arterial hypertension in adults: update of the CHEST guideline and expert panel report. Chest 2019; 155: 565.Google Scholar
Klok, FA, Delcroix, M, Bogaard, HJ. Chronic thromboembolic pulmonary hypertension from the perspective of the patient with pulmonary embolism. J Thromb Haemost 2018; 16: 1040.Google Scholar
Langleben, D. Endothelin receptor antagonists in the treatment of pulmonary arterial hypertension. Clin Chest Med 2007; 28: 117.Google Scholar
Libby, DM, Briscoe, WA, Boyce, B, et al. Acute respiratory failure in scoliosis or kyphosis: prolonged survival and treatment. Am J Med 1982; 73: 532.Google Scholar
Martin, KB, Klinger, JR, Rounds, SIS. Pulmonary arterial hypertension: new insights and new hope. Respirology 2006; 11: 6.Google Scholar
McGregor, M, Sniderman, A. On pulmonary vascular resistance: the need for more precise definition. Am J Cardiol 1985; 55: 217.Google Scholar
Moll, M, Sardana, M, Farber, HW. Pulmonary hypertension, cor pulmonale, and other pulmonary vascular conditions. In: Scientific American Medicine. Pulmonary & Critical Care Medicine. Hamilton: Dekker Medicine. 2020.Google Scholar
Naeije, R. Pulmonary vascular resistance: a meaningless variable? Crit Care Med 2003; 29: 526.Google Scholar
Newman, JH. Treatment of primary pulmonary hypertension – the next generation. N Engl J Med 2002; 346: 933.Google Scholar
Niemann, CU, Mandell, SM. Pulmonary hypertension and liver transplantation. Pulmonary Perspectives 2003; 20(1): 4.Google Scholar
Palevsky, HI, Fishman, AP. The management of primary pulmonary hypertension. JAMA 1991; 265: 1014.Google Scholar
Pengo, V, Lensing, AW, Prins, MH, et al. Incidence of chronic thromboembolic pulmonary hypertension after pulmonary embolism. N Engl J Med 2004; 350: 2257.Google Scholar
Pepke-Zaba, J, Higenbottam, TW, Dinh-Xuan, AT, et al. Inhaled nitric oxide as a cause of selective pulmonary vasodilatation in pulmonary hypertension. Lancet 1991; 338: 1173.Google Scholar
Prasad, S, Wilkinson, J, Gatzoulis, MA. Sildenafil in primary pulmonary hypertension. N Engl J Med 2000; 343: 1342.Google Scholar
Prior, DL, Adamas, H, Williams, TJ. Update on pharmacotherapy for pulmonary hypertension. Med J Aust 2016; 205: 271.Google Scholar
Rich, S. The current treatment of pulmonary arterial hypertension: time to redefine success. Chest 2006; 130: 1198.Google Scholar
Rich, S, Herskowitz, A, eds. Pulmonary vascular disease: the global perspective. Chest 2010; 6 (suppl.): 1S.Google Scholar
Rich, S, Rubin, L, Walker, AM, et al. Anorexigens and pulmonary hypertension in the United States. Chest 2000; 117: 870.Google Scholar
Robalino, BD, Moodie, DS. Association between pulmonary hypertension and portal hypertension: analysis of its pathophysiology and clinical, laboratory and hemodynamic manifestations. J Am Coll Cardiol 1991; 17: 492.Google Scholar
Roberts, WC. A simple histologic classification of pulmonary arterial hypertension. Am J Cardiol 1986; 58: 385.Google Scholar
Rubin, LJ, ed. Brenot memorial symposium on the pathogenesis of primary pulmonary hypertension. Chest 1998; 114: no.3 (suppl.).Google Scholar
Rubin, LJ. Therapy of pulmonary hypertension: targeting pathogenic mechanisms with selective treatment delivery. Crit Care Med 2001; 29: 1086.Google Scholar
Rubin, LJ, ed. Diagnosis and management of pulmonary arterial hypertension: ACCP evidence-based clinical practice guidelines. Chest 2004; 126: no.1 (suppl.).Google Scholar
Rubin, LJ, Badesch, DB, Barst, RJ, et al. Bosentan therapy for pulmonary artery hypertension. N Engl J Med 2002; 346: 896.Google Scholar
Salvador, ML, Loaiza, CAQ, Padial, LR, et al. Portopulmonary hypertension: prognosis and management in the current treatment era – results from the REHAP registry. Intern Med J 2021; 51: 355.Google Scholar
Shah, SJ, Gomberg-Maitland, M, Thenappan, T, et al. Selective serotonin reuptake inhibitors and the incidence and outcome of pulmonary hypertension. Chest 2009; 136: 694.Google Scholar
Shure, D. Primary pulmonary hypertension – good news and bad. Pulmonary Perspectives 1996; 13(3): 6.Google Scholar
Simonneau, G, Galie, N, Rubin, LJ, et al. Clinical classification of pulmonary hypertension. J Am Coll Cardiol 2004; 43: 5S.Google Scholar
Smith, I. Pulmonary hypertension: an overview for the non-cardiac anaesthetist. In: Riley, R, ed. Australasian Anaesthesia. Melbourne: ANZCA. 2015; p 75.Google Scholar
Taichman, DB, Omelas, J, Chung, L, et al. Pharmacologic therapy for pulmonary arterial hypertension in adults: CHEST guideline and expert panel report. Chest 2014; 146: 449.Google Scholar
Various. 47th annual Thomas L Petty lung conference: cellular and molecular pathobiology of pulmonary hypertension. Chest 2005; 128 (suppl.): 547S.Google Scholar
Versprille, A. Pulmonary vascular resistance: a meaningless variable. Intens Care Med 1984; 10: 51.Google Scholar
Walmrath, D, Schneider, T, Pilch, J, et al. Effects of aerosolized prostacyclin in severe pneumonia. Am J Respir Crit Care Med 1995; 151: 724.Google Scholar
Winter, M-P, Schernthaner, GH, Lang, IM. Chronic complications of venous thromboembolism. J Thromb Haemost 2017; 15: 1531.Google Scholar
Bibliography
Crystal, RG, Bitterman, PB, Rennard, SI, et al. Interstitial lung diseases of unknown cause. N Engl J Med 1984; 310: 154 & 235.Google Scholar
Muller, NL, Miller, RR. Computed tomography of chronic diffuse infiltrative lung disease. Am Rev Respir Dis 1990; 142: 1440.Google Scholar
Bibliography
Baldwin, DR. Development of guidelines for the management of pulmonary nodules. Chest 2015; 148: 1365.Google Scholar
Cruickshank, A, Stieler, G, Ameer, F. Evaluation of the solitary pulmonary nodule. Intern Med J 2019; 49: 306.Google Scholar
Dines, DE, Arms, RA, Bernatz, PE, et al. Pulmonary arteriovenous fistulas. Mayo Clin Proc 1974; 48: 460.Google Scholar
Faughnan, ME, Lui, YW, Wirth, JA, et al. Diffuse pulmonary arteriovenous malformations: characteristics and prognosis. Chest 2000; 117: 31.Google Scholar
Gould, MK, Tang, T, Liu, IL, et al. Recent trends in the identification of incidental pulmonary nodules. Am J Respir Crit Care Med 2015; 192: 1208.Google Scholar
Lee, P, Minai, OA, Mehta, AC, et al. Pulmonary nodules in lung transplant recipients: etiology and outcome. Chest 2004; 125: 165.Google Scholar
MacMahon, H, Naidich, DP, Goo, JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology 2017; 284: 228.Google Scholar
Ost, D, Fein, A. Evaluation and management of the solitary pulmonary nodule. Am J Respir Crit Care Med 2000; 162: 782.Google Scholar
Patel, VK, Naik, SK, Naidich, DP, et al. A practical algorithmic approach to the diagnosis and management of solitary pulmonary nodules: Parts 1 & 2. Chest 2013; 143: 825 & 840.Google Scholar
Terry, PB, Barth, KH, Kaufman, SL, et al. Balloon embolization for the treatment of pulmonary arteriovenous fistulas. N Engl J Med 1980; 302: 1189.Google Scholar
Wiener, DC, Wiener, RS. Patient-centred guideline-concordant discussion and management of pulmonary nodules. Chest 2020; 158: 416.Google Scholar
White, RJ, Lynch-Nyhan, A, Terry, P, et al. Pulmonary arteriovenous malformation: techniques and long-term outcome of embolotherapy. Radiology 1988; 169: 663.Google Scholar
Bibliography
Heath, D, Segal, N, Bishop, J. Pulmonary veno-occlusive disease. Circulation 1966; 34: 242.Google Scholar
Holcomb, BW, Loyd, JE, Ely, EW, et al. Pulmonary veno-occlusive disease. Chest 2000; 118: 1671.Google Scholar
Palevsky, HI, Pietra, GG, Fishman, AP. Pulmonary veno-occlusive disease and its response to vasodilator agents. Am Rev Respir Dis 1990; 142: 426.Google Scholar
Palmer, SM, Robinson, LJ, Wand, A, et al. Massive pulmonary edema and death after prostacyclin infusion in a patient with pulmonary veno-occlusive disease. Chest 1998; 113: 237.Google Scholar
Bibliography
Bick, R. Vascular thrombohaemorrhagic disorders: hereditary and acquired. Clin Appl Thromb Hemost 2001; 7: 178.Google Scholar
Cameron, JS. Henoch-Schonlein purpura: clinical presentation. Contrib Nephrol 1984; 40: 246.Google Scholar
Connell, NT. Microangiopathic and vascular disorders. In: Scientific American Medicine. Hematology. Hamilton: Dekker Medicine. 2020.Google Scholar
Thachil, J. History of the word ‘purpura’ and its current relevance. J Thromb Haemost 2021; 191: 2381.Google Scholar
Bibliography
Cooper, A, Powell, FC. Pyoderma gangrenosum – a frequently misdiagnosed skin condition. Med J Aust 2013; 199: 382.Google Scholar
Hecker, MS, Lebwohl, MG. Recalcitrant pyoderma gangrenosum: treatment with thalidomide. J Am Acad Dermatol 1998; 38: 490.Google Scholar
Schwaegerle, SM, Bergfeld, WF, Senitzer, D, et al. Pyoderma gangrenosum: A review. J Am Acad Dermatol 1988; 18: 559.Google Scholar
Teagle, A, Hargest, R. Management of pyoderma gangrenosum. J R Soc Med 2014; 107: 228.Google Scholar
Bibliography
Aduan, RP, Fauci, AS, Dale, DC, et al. Factitious fever and self-induced infection. Ann Intern Med 1979; 90: 230.Google Scholar
Aronoff, DM, Neilson, EC. Antipyretics: mechanisms of action and clinical use in fever suppression. Am J Med 2001; 111: 304.Google Scholar
Axelrod, P. External cooling in the management of fever. Clin Infect Dis 2000; 31: S224.Google Scholar
Beresford, RW, Gosbell, IB. Pyrexia of unknown origin: causes, investigation and management. Intern Med J 2016; 46: 1011.Google Scholar
Bernheim, HA, Block, LH, Atkins, E. Fever: pathogenesis, pathophysiology, and purpose. Ann Intern Med 1979; 91: 261.Google Scholar
Dallimore, J, Ebmeier, S, Thayabaran, D, et al. Effect of active temperature management on mortality in intensive care patients. Crit Care Resusc 2018; 20: 150.Google Scholar
Dinarello, CA, Cannon, JG, Wolff, SM. New concepts on the pathogenesis of fever. Rev Infect Dis 1988; 10: 168.Google Scholar
Drenth, JPH, van der Meer, JWM. Hereditary periodic fever. New Engl J Med 2001; 345: 1748.Google Scholar
Eliakim, M, Levy, M, Ehrenfeld, M. Recurrent Polyserositis (Familial Mediterranean Fever, Periodic Disease). Amsterdam: Elsevier. 1981.Google Scholar
Gherardin, A, Sisson, J. Assessing fever in the returned traveller. Aust Prescriber 2012; 35; 10.Google Scholar
Hasday, JD, Garrison, A. Antipyretic therapy in sepsis. Clin Infect Dis 2000; 31: S234.Google Scholar
Knockaert, DC, Vanneste, LJ, Vanneste, SB, et al. Fever of unknown origin in the 1980s. Arch Intern Med 1992; 152: 51.Google Scholar
Laupland, KB. Fever in the critically ill patient. Crit Care Med 2009; 37 (suppl.): S273.Google Scholar
Laupland, KB, Shahpori, R, Kirkpatrick, AW, et al. Occurrence and outcome of fever in critically ill adults. Crit Care Med 2008; 36: 1531.Google Scholar
Lefrant, J-Y, Muller, L, Coussaye, JE, et al. Temperature measurement in intensive care patients: comparison of urinary bladder, oesophageal, rectal, axillary, and inguinal methods versus pulmonary artery core method. Intens Care Med 2003; 29: 414.Google Scholar
Mackowiak, PA. Fever: blessing or curse? A unifying hypothesis. Ann Intern Med 1994; 120: 1037.Google Scholar
Mackowiak, PA, LeMaistre, CF. Drug fever: a critical appraisal of conventional concepts. Ann Intern Med 1987; 106: 728.Google Scholar
Musher, DM, Fainstein, V, Young, EJ. Fever patterns: their lack of clinical significance. Arch Intern Med 1979; 139: 1225.Google Scholar
Netea, MG, Kullberg, BJ, Van der Meer, JW. Circulating cytokines as mediators of fever. Clin Infect Dis 2000; 31: S178.Google Scholar
Nimmo, SM, Kennedy, BW, Tullet, WM, et al. Drug-induced hyperthermia. Anaesthesia 1993; 48: 892.Google Scholar
O’Grady, NP, Barie, PS, Bartlett, J, et al. Practice guidelines for evaluating new fever in critically ill adult patients. Crit Care Med 1998; 26: 392.Google Scholar
Olson, KR, Benowitz, NL. Environmental and drug-induced hyperthermia: pathophysiology, recognition and management. Emerg Med Clin North Am 1984; 2: 459.Google Scholar
Plaisance, KI, Mackowiak, PA. Antipyretic therapy: physiologic rationale, diagnostic implications, and clinical consequences. Arch Intern Med 2000; 160: 449.Google Scholar
Point/Counterpoint Editorial. Should antipyretic therapy be given routinely to febrile patients in septic shock? Yes or no. Chest 2013; 144: 1096 & 1098.Google Scholar
Reny, J-L, Vuagnat, A, Ract, C, et al. Diagnosis and follow-up of infections in intensive care patients: value of C-reactive protein compared with other clinical and biological variables. Crit Care Med 2002; 30: 529.Google Scholar
Roberts, NJ. Impact of temperature elevation on immunologic defenses. Rev Infect Dis 1991; 13: 462.Google Scholar
Rosenberg, J, Pentel, P, Pond, S, et al. Hyperthermia associated with drug intoxication. Crit Care Med 1986; 14: 964.Google Scholar
Shafazand, S, Weinacker, AB. Blood cultures in the critical care unit: improving utilization and yield. Chest 2002; 122: 1727.Google Scholar
Simon, HB. Hyperthermia, fever, and fever of undetermined origin. In: Scientific American Medicine. Infectious Diseases. Hamilton: Dekker Medicine. 2020.Google Scholar
Simon, HB, Daniels, GH. Hormonal hyperthermia: endocrinologic causes of fever. Am J Med 1979; 66: 257.Google Scholar
Young, PJ, Prescott, HC. When less is more in the active management of elevated body temperature of ICU patients. Intens Care Med 2019; 45: 1275.Google Scholar
Bibliography
Dempsey, GA, Lyall, HJ, Corke, CF, et al. Pyroglutamic acidemia: a cause of high anion gap metabolic acidosis. Crit Care Med 2000; 28: 1803.Google Scholar
Mo, L, Lliang, DL, Madden, A, et al. A case of delayed onset pyroglutamic acidosis in the sub-acute setting. Intern Med J 2016; 46: 747.Google Scholar